2024 annual financial data
Korro Bio 2024 Operating margin
Direct answer
Operating margin was -4,047.12%.
Operating income was -91,910,000 USD and net income was -83,581,000 USD.
Operating cash flow was -60,074,000 USD.
Get free Korro Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,271,000 USD
- Operating income
- -91,910,000 USD
- Net income
- -83,581,000 USD
- Operating cash flow
- -60,074,000 USD